Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Merck KGaA (MKKGY) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$5.78B
Net Income	$708.26M
Cost of Goods Sold	$2.48B
Gross Profit	$3.30B
Operating Expenses	$4.91B
Operating Income	$874.31M
Non-Operating Income/Expense	$-16.29M
Pre-Tax Income	$858.01M
Normalized Pre-Tax Income	$858.01M
Income after Taxes	$710.34M
Income from Continuous Operations	$711.43M
Consolidated Net Income/Loss	$711.43M
Normalized Income after Taxes	$710.34M
EBIT	$874.31M
EBITDA	$1.44B
Weighted-Average Shares Outstanding (Basic)	434.78M
Weighted-Average Shares Outstanding (Diluted)	434.78M
Earnings per Share (EPS) (Basic)	$4.22
Earnings per Share (EPS) (Diluted)	$4.22
Balance Sheet Financials
Current Assets	$14.55B
Property, Plant, and Equipment	$10.85B
Long-Term Assets	$41.25B
Total Assets	$55.80B
Current Liabilities	$12.22B
Long-Term Debt	$7.57B
Long-Term Liabilities	$11.13B
Total Liabilities	$23.35B
Common Equity	$32.45B
Tangible Shareholders Equity	$4.93B
Shareholders Equity	$32.45B
Common Shares Outstanding	434.78M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.96B
Cash Flow from Investing Activities	$-3.30B
Cash Flow from Financial Activities	$-1.07B
Beginning Cash	$2.14B
End Cash	$2.72B
Increase/Decrease in Cash	$578.92M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-1.13B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.19
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.19
Debt to Equity Ratio	0.34
Gross Margin	57.17%
Operating Margin	15.13%
EBIT Margin	15.13%
EBITDA Margin	--
Pre-Tax Profit Margin	14.84%
Profit Margin	12.25%
Free Cash Flow	$3.15B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.51
Receiveable Turnover	1.20
Days Sales in Receivables	75.13
Return on Equity	2.19%
Return on Tangible Equity	14.44%
Return on Assets	1.27%
Return on Investments	1.78%
Book Value Per Share	$74.64
Free Cash Flow per Share	$7.25
Operating Cash Flow per Share	$11.41

Data from Zacks Investment Research, Inc.